Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001214659-25-016718·Octagon Capital Advisors LP
Schedule 13G ownership disclosure
Taysha Gene Therapies Inc
Common Stock, $0.00001 par value · CUSIP: 877619106
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Octagon Capital Advisors LP
Shares: 9,067,500.00 · Class: 3.3%
- Octagon Investments Master Fund
Shares: 9,067,500.00 · Class: 3.3%
- Ting Jia
Shares: 9,067,500.00 · Class: 3.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-016718
- Form type
- SCHEDULE 13G/A
- Filer
- Octagon Capital Advisors LP
- CIK
- CIK 1839435
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership